MUFG Securities EMEA’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Buy |
+307
| New | +$161K | 0.2% | 135 |
|
|
2022
Q4 | – | Sell |
-135
| Closed | -$93K | – | 138 |
|
|
2022
Q3 | $93K | Hold |
135
| – | – | ﹤0.01% | 91 |
|
|
2022
Q2 | $80K | Hold |
135
| – | – | ﹤0.01% | 74 |
|
|
2022
Q1 | $94K | Hold |
135
| – | – | ﹤0.01% | 109 |
|
|
2021
Q4 | $85K | Hold |
135
| – | – | ﹤0.01% | 153 |
|
|
2021
Q3 | $82K | Sell |
135
-645
| -83% | -$392K | ﹤0.01% | 256 |
|
|
2021
Q2 | $436K | Sell |
780
-2,100
| -73% | -$1.17M | ﹤0.01% | 244 |
|
|
2021
Q1 | $1.36M | Buy |
2,880
+1,700
| +144% | +$805K | 0.01% | 273 |
|
|
2020
Q4 | $570K | Buy |
1,180
+559
| +90% | +$270K | ﹤0.01% | 329 |
|
|
2020
Q3 | $348K | Buy |
+621
| New | +$348K | ﹤0.01% | 342 |
|
|
2020
Q2 | – | Sell |
-1,280
| Closed | -$625K | – | 480 |
|
|
2020
Q1 | $625K | Sell |
1,280
-1,600
| -56% | -$781K | 0.01% | 346 |
|
|
2019
Q4 | $1.08M | Buy |
2,880
+2,004
| +229% | +$752K | 0.01% | 412 |
|
|
2019
Q3 | $243K | Sell |
876
-59,792
| -99% | -$16.6M | ﹤0.01% | 302 |
|
|
2019
Q2 | $19M | Buy |
60,668
+57,872
| +2,070% | +$18.1M | 0.2% | 85 |
|
|
2019
Q1 | $1.15M | Sell |
2,796
-2,690
| -49% | -$1.1M | 0.01% | 368 |
|
|
2018
Q4 | $2.05M | Sell |
5,486
-5,266
| -49% | -$1.97M | 0.02% | 224 |
|
|
2018
Q3 | $4.34M | Buy |
10,752
+1,721
| +19% | +$695K | 0.06% | 159 |
|
|
2018
Q2 | $3.12M | Buy |
9,031
+152
| +2% | +$52.4K | 0.06% | 157 |
|
|
2018
Q1 | $3.06M | Sell |
8,879
-43,739
| -83% | -$15.1M | 0.06% | 137 |
|
|
2017
Q4 | $19.8M | Buy |
52,618
+49,070
| +1,383% | +$18.4M | 0.46% | 45 |
|
|
2017
Q3 | $1.59M | Buy |
3,548
+1,625
| +85% | +$726K | 0.06% | 73 |
|
|
2017
Q2 | $944K | Sell |
1,923
-3,716
| -66% | -$1.82M | 0.04% | 52 |
|
|
2017
Q1 | $2.19M | Buy |
5,639
+3,802
| +207% | +$1.47M | 0.11% | 26 |
|
|
2016
Q4 | $674K | Buy |
1,837
+764
| +71% | +$280K | 0.06% | 12 |
|
|
2016
Q3 | $431K | Buy |
+1,073
| New | +$431K | 0.39% | 14 |
|